Calamos Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Calamos Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$71.48 - $86.85 $7.86 Million - $9.55 Million	-110,000 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$74.28 - $92.69 $1.19 Million - $1.48 Million	16,000 Added 17.02%	110,000 $8.48 Million
Q4 2021 Feb 01, 2022	SELL	$71.72 - $91.47 $4.72 Million - $6.02 Million	-65,791 Reduced 41.17%	94,000 $8.31 Million
Q2 2020 Jul 27, 2020	SELL	$79.55 - $124.22 $119,325 - $186,330	-1,500 Reduced 0.93%	159,791 $19.7 Million
Q1 2020 Apr 28, 2020	BUY	$71.37 - $96.85 $11.5 Million - $15.6 Million	161,291 New	161,291 $13.6 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.